Author:
Moitra Subhabrata,Limaye Sneha,Brashier Bill
Reference89 articles.
1. de Boer WI, Yao H, Rahman I (2007) Future therapeutic treatment of COPD: struggle between oxidants and cytokines. Int J Chron Obstruct Pulmon Dis 2:205–228
2. Rahman I, MacNee W (2000) Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16:534–554
3. Day BJ (2009) Catalase and glutathione peroxidase mimics. Biochem Pharmacol 1(77):285–296
4. Chae HZ, Kang SW, Rhee SG (1999) Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300:219–226
5. Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R et al (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo controlled Trial. Lancet 365:1552–1560